Secondary
Dova Pharmaceuticals, Inc.
Dova is a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for rare diseases where there is a high unmet need, with an initial focus on addressing thrombocytopenia.
Symbol
DOVA
Last Closing Price
$32.88
Effective Date
February 23, 2018
Underwriters
J.P. Morgan, Jefferies, Evercore ISI
To view the prospectus for Dova Pharmaceuticals, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277